GFM
LGND icon

GF Fund Management’s Ligand Pharmaceuticals LGND Stock Holding History

GF Fund Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.4K Buy
443
+57
+15% +$11.3K ﹤0.01% 349
2025
Q4 		$73K Sell
386
-36
-9% -$6.92K ﹤0.01% 372
2025
Q3 		$74.8K Sell
422
-62
-13% -$9.22K ﹤0.01% 358
2025
Q2 		$55K Hold
484
– – ﹤0.01% 406
2025
Q1 		$50.9K Buy
484
+87
+22% +$9.84K ﹤0.01% 418
2024
Q4 		$42.5K Buy
+397
New +$44.9K ﹤0.01% 403

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

GF Fund Management's LGND Position: Q1 2026 in Review

GF Fund Management increased its Ligand Pharmaceuticals (LGND) stake by 15% in Q1 2026, buying an estimated $11.3K and bringing the position to 443 shares worth $88.4K. The position accounts for ﹤0.01% of the portfolio, ranked #349.

GF Fund Management first reported a position in LGND in Q4 2024 and has held it in 6 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • GF Fund Management held 443 shares of Ligand Pharmaceuticals worth $88.4K as of Q1 2026.
  • GF Fund Management bought 57 Ligand Pharmaceuticals shares in Q1 2026, an estimated $11.3K.
  • Ligand Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #349 holding.
  • GF Fund Management first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.